US Patent 7094535 Nucleic acid ligands to integrins
Patent 7094535 was granted and assigned to Gilead Sciences on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew Stephens0
Judy Ruckman0
Larry Gold0
Nebojsa Janjic0
Edits on 29 Aug, 2023
Golden AI
Edits made to:
Article (+298 characters)
Article
Patent abstract
Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07094535 Nucleic acid ligands to integrins US Patent 7094535 Nucleic acid ligands to integrins
Infobox
Patent Number
070945350
Patent Number
70945350
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
070945350
Date of Patent
August 22, 2006
0Patent Application Number
100249970
Date Filed
December 18, 2001
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07094535 Nucleic acid ligands to integrins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07094535
Date of patent
August 22, 2006
Patent application number
10024997
Date Filed
December 18, 2001
Patent primary examiner
Find more entities like US Patent 7094535 Nucleic acid ligands to integrins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
